‍

We're pleased to share the latest progress from our research teams as we continue our pre-clinical work.

Pre-Clinical Research Progress

  • Biocompatibility Testing: We've completed biocompatibility testing on 20 out of 20 samples, and the preliminary results are highly promising. This is a major step forward in confirming the safety of our material.
  • Histology and DNA Quantification: Out of the 20 samples tested for biocompatibility, 10 have also completed the histology and DNA quantification processes. We anticipate having all 20 samples fully analyzed by mid-October.
  • Protocol Enhancements: Our decellularization and recellularization protocols have been refined to include screening for specific toxins. This modification is designed to ensure the samples are fully sterile, thereby ensuring maximum safety and sterility.

International Collaborations and Publications

  • Slovakian Bioreactor Grant: Our research partners in Slovakia were recently awarded an independent grant to further refine their bioreactor technology. While this grant was applied for separately from Foregen, the resulting improvements to the bioreactor can be directly applied to multiple projects, including ours, enhancing our overall process.
  • Journal Submissions:
    • Animal Trial Results: Dr. Palumbo is currently awaiting feedback from the journal where her team submitted the results of the animal trials conducted in Italy. We will share an update as soon as we receive news.
    • Future Publications: Following the completion of this current pre-clinical research project, the team believes we will be able to write and publish 2 to 3 articles sharing the methods and results with the wider scientific community.

Foregen Community and Financials

  • Lab Tour Series: Work on the next episode of our popular lab tour series is underway! Stay tuned for a behind-the-scenes look at our latest developments.

September Fundraising: We are incredibly grateful for the continued support of our community. In September, we successfully raised a total of $23,286. Your donations are what make this research possible.